Ilaprazole

Ilaprazole

Systematic (IUPAC) name
2-[(RS)-[(4-methoxy-3-methylpyridin-2-yl)methyl]sulfinyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole
Clinical data
Trade names	Noltec
Routes of administration	oral
Identifiers
CAS Registry Number	172152-36-2
ATC code	None
PubChem	CID 214351
ChemSpider	185839
UNII	776Q6XX45J Y
Chemical data
Formula	C19H18N4O2S
Molecular mass	366.436820 g/mol
SMILES CC1=C(C=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)N4C=CC=C4)OC
InChI InChI=1S/C19H18N4O2S/c1-13-17(20-8-7-18(13)25-2)12-26(24)19-21-15-6-5-14(11-16(15)22-19)23-9-3-4-10-23/h3-11H,12H2,1-2H3,(H,21,22) Key:HRRXCXABAPSOCP-UHFFFAOYSA-N

Ilaprazole (trade name Noltec) is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer. It is available in strengths of 5, 10, and 20 mg.

Clinical studies show that ilaprazole is at least as potent a PPI as omeprazole when taken in equivalent doses. Studies also showed that ilaprazole significantly prevented the development of reflux oesophagitis.

Ilaprazole is developed by IL-YANG Pharmaceutical (Korea), and is still under clinical trials with US FDA. It has launched in Korea and China for the treament of GU, DU, and GERD/EE.^[1]

References